Differing adult uptakes, healthcare systems and cultures of medicine have played role in approaches
The UK and US may have many things in common, but when it comes to vaccinating children against Covid, the approach has been markedly different.
In May, the US Food and Drug Administration’s emergency use authorisation of the Pfizer/BioNTech jab was expanded from people aged 16 and older to those aged 12 to 15, with two doses recommended for all those eligible.
